NEW YORK, Aug. 19, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI), a company dedicated to the research, development and marketing of "whole plant" nutraceuticals and pharmaceuticals, announced today that it has terminated its relationship with Global Media Products (GMP). GMP was retained in 2003 to produce an infomercial on Lo-Chol(tm), the Company's patented "healthy cholesterol" product.
In addition, pursuing to the terms of the agreement, APPI's agreement with Ed McMahon expired on June 13, 2004.
"We are actively reviewing other companies to promote and market Lo-Chol(tm)," stated David Lieberman, CEO of APPI. "We have gained quite a bit of insight into the process of commercial and infomercial production, and will utilize the experience gained to align ourselves with the best people in the business."
The mainstream pharmaceuticals being prescribed for high cholesterol are known as "statins." Like many chemical-based drugs, statins can cause negative side effects, especially in those patients with weaker kidney and liver functions. APPI believes that Lo-Chol(tm) provides a natural, healthy alternative for people seeking an alternative way to maintain healthy cholesterol levels.
About Advanced Plant Pharmaceuticals:
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of whole plant-based products. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements.
For more information, visit the Company's Corporate website: www.advancedplantpharm.com
Forward-Looking Statements:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.